Trieu Vuong's Form 4 filing
Oncotelic Therapeutics, Inc. (OTLC) · filed Jan 31, 2025
- Accession no.
- 0001493152-25-004486
- Filed
- Jan 31, 2025, 5:08 PM ET
- Trade date
- Jan 29-31, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.71K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Trieu VuongCIK 0001587074 | Director, Officer (CHAIRMAN AND CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | Common Stock | PPurchaseAcquired | +183,066 | $0.028 | +$5,125.85 | 93,025,782 | Direct | |
| Jan 30, 2025 | Common Stock | PPurchaseAcquired | +100,003 | $0.028 | +$2,800.08 | 93,125,785 | Direct | |
| Jan 31, 2025 | Common Stock | PPurchaseAcquired | +63,775 | $0.028 | +$1,785.7 | 93,189,560 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.